Researchers at The University of Texas MD Anderson Cancer Center have identified a key enzyme—RNase H2—that helps ...

A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...

A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have ...

LiquidCell Dx, a next generation cancer diagnostics company, today announced publication in Nature of critical research underpinning the development of LiquidTME, its blood-based assay for tumor ...

A bone marrow transplant can buy time for people with aggressive B-cell cancers. Too often, it does not buy enough. For ...

Many supplements promise to help you live longer, but aren't actually backed by science. Here are the ones doctors actually ...

There is a small organ sitting behind your breastbone, roughly the size of a walnut in adults, that most physicians have ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Researchers at MD Anderson have identified RNase H2 as a key survival mechanism in triple-negative breast cancer, helping ...

A newly developed therapy inspired by bacteria residing within tumors offers a different way to combat cancer by targeting ...

Cancer cell biology has rapidly evolved into a cornerstone of contemporary cancer research, driving the integration of molecular, structural, and ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...